Conversely, a Th1 phenotype in breast cancer is associated with prolonged patient survival, whereby women with the highest ratios of Th1 cytokines to IL-5 levels were least likely to have aggressive phenotypes of breast cancer (oestrogen receptor negative [ER−] and triple negative breast cancer [TNBC]) [133]. Here, IL5 is linked to breast carcinoma.